로딩 중…
지수 로딩 중…
Monte Rosa Therapeutics, Inc.
GLUE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$18.31-0.54%
2026-06-18
Price Chart
Monte Rosa Therapeutics, Inc.+307.80%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.55B |
| Revenue | $43M |
| Net Income | $-130M |
| Total Assets | $736M |
| Net Assets | $522M |
| Value | |
| P/B | 2.96x |
| P/S | 36.01x |
| FCF Yield | -1.27% |
| Profitability | |
| ROE | -24.91% |
| ROA | -17.65% |
| Op. Margin | -345.21% |
| Revenue Growth | -95.04% |
| Earnings Growth | -194.92% |
| Financial Health | |
| Debt Ratio | 41.10% |
| Total Debt | $39M |
| FCF | $-20M |
| Cash | $160M |
| Current Ratio | 9.54x |
| Performance | |
| 1Y Return | 307.80% |
| 1M Return | 4.15% |
| From 52W High | -28.95% |
| 1Y MDD | -41.84% |
| Trading | |
| Volume | 1,778,232 shares |
| Trading Value | $33M |
| Per Share | |
| EPS | $-0.59 |
| BPS | $3.56 |